Molecular Devices Introduces Integrated Microplate Washer and Four-Fluid Dispenser
February 12 2004 - 2:33PM
PR Newswire (US)
Molecular Devices Introduces Integrated Microplate Washer and
Four-Fluid Dispenser SUNNYVALE, Calif., Feb. 12
/PRNewswire-FirstCall/ -- Molecular Devices Corporation today
announced the introduction of the AquaMax(R) DW4 liquid handling
system to their expanding line of liquid handling products. The
system integrates four-fluid dispensing and washing into one
compact instrument. The AquaMax DW4 is the only system to handle
1536-well washing, as well as 96- and 384-well low-volume formats.
Developed for life scientists and drug discovery researchers, the
system provides better results with adherent and non-adherent cell
lines and beads, and improved productivity over current dispensers.
Windows(R)-compatible software gives the user the flexibility to
easily program multiple dispense and wash procedures. Commenting on
the introduction, Dr. Stephen J. Oldfield, Vice President of
Worldwide Marketing at Molecular Devices stated, "ELISAs, kinase,
phosphatase, and GPCR-type assays that require washing and multiple
dispensing steps can now be done on one compact unit -- there is no
need for multiple instruments. The small footprint saves valuable
space in the lab and the system's low-volume dispense capability
saves in costly reagent usage -- for 384-well low-volume
microplates, dispensing has been optimized down to 0.5 microliter.
Furthermore, the user can easily expand throughput capabilities by
upgrading from 96-well through 1536-well in one system." Molecular
Devices Corporation is a leading supplier of high-performance
bioanalytical measurement systems that accelerate and improve drug
discovery and other life sciences research. The Company's systems
and consumables enable pharmaceutical and biotechnology companies
to leverage advances in genomics, proteomics and combinatorial
chemistry by facilitating the high-throughput and cost-effective
identification and evaluation of drug candidates. The Company's
solutions are based on its advanced core technologies that
integrate its expertisein engineering, molecular and cell biology
and chemistry. Molecular Devices enables its customers to improve
research productivity and effectiveness, which ultimately
accelerates the complex process of discovering and developing new
drugs. This pressrelease contains "forward-looking" statements,
including statements related to the prospects for or potential
customer use of the AquaMax(R) DW4 liquid handling system. Any
statements contained in this press release that are not statements
of historical fact may be deemed to be forward-looking statements.
Words such as "believes," "anticipates," "plans," "expects,"
"will," and similar expressions are intended to identify
forward-looking statements. There are a number of important factors
that could cause the results of Molecular Devices Corporation to
differ materially from those indicated by these forward-looking
statements, including, among others, risks detailed from time to
time in the Company's SEC reports, including its Annual Report on
Form 10-K for the year ended December 31, 2002 and its quarterly
report on Form 10-Q for the quarter ended September 30, 2003.
Molecular Devices Corporation does not undertake any obligation to
update forward-looking statements. DATASOURCE: Molecular Devices
Corporation CONTACT: Tim Harkness of Molecular Devices Corporation,
+1-408-747-3533 Web site: http://www.moleculardevices.com/
Copyright
Molecular Devices (NASDAQ:MDCC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Molecular Devices (NASDAQ:MDCC)
Historical Stock Chart
From Jul 2023 to Jul 2024